Kozak & Associates, Inc. Novartis Ag Transaction History
Kozak & Associates, Inc.
- $524 Million
- Q3 2025
A detailed history of Kozak & Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Kozak & Associates, Inc. holds 21 shares of NVS stock, worth $2,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 1,000
97.9%
Holding current value
$2,762
Previous $121,000
98.35%
% of portfolio
0.0%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...